Viewing Study NCT05422027

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:06 AM

Ignite Modification Date: 2026-01-07 @ 1:35 PM

Study NCT ID: NCT05422027

Status: RECRUITING

Last Update Posted: 2024-06-17

First Post: 2022-06-13

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma

Sponsor: Xia Zhongjun

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module